• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

SARS-CoV-2 Preferentially Binds Blood Group A

August 9, 2023

Many studies have noted an association between ABO blood group antigens and susceptibility to infection—most commonly that individuals with blood group A are at an increased risk of SARS-CoV-2 infection compared to individuals with blood group O.  Until recently, the mechanism to explain this association has not been understood.  Researchers noted that the receptor binding domain (RBD) of the SARS-CoV-2 spike protein that binds host epithelial cells shares homology with galectins—an ancient family of carbohydrate binding proteins.  Based on a glycan microarray populated with distinct variants of human ABO antigens, researchers found that the SARS-CoV-2 RBD had an overlapping binding profile to galectin-4.  Furthermore, using cell cultures expressing both human angiotensin-converting enzyme 2 (ACE2) and type 1 blood group A or O antigens normally found on respiratory epithelial cells, researchers observed the highest RBD binding toward blood group A expressing cells with the Omicron variant RBD.  In addition, pre-incubation of the cells with galectin-4 inhibited SARS-CoV-2 infections of cells expressing blood group A but not blood group O.  In contrast, galectin 1 (which does not bind any blood group antigens) failed to influence SARS-CoV-2 infection susceptibility.  While many factors influence overall susceptibility to SARS-CoV-2 infection, these results help to explain why individuals with blood group A antigen may be more at risk for infection.

Reference:

SC Wu, CM Arthur, HM Jan, WF Garcia-Beltran, et al. Blood Group A Enhances SARS-CoV-2 Infection. Blood 2023; blood.2022018903

Filed Under

  • News
  • Serology/Genotyping

Recommended

  • West Nile Virus Outbreak in the United States

  • CRISPR-Gene Editing Uses for Transfusion Medicine

  • FDA Advisory Committee Supports Molecular Assay

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley